Gunjan Verma - India

“This extension will ensure that manufacturers with pending Class C or D Import License applications do not incur any interruptions to their importing activities.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sign Up For Our Newsletter to Stay Informed

Sign Up

India Grants Class C and D Import License Grace Period

Published on: September 16th, 2023

Provides Manufacturers with an Additional 6 Months to Complete Application Process

On October 12, 2023, the Central Drugs Standard Control Organisation (CDSCO) issued Circular File No. 29/Misc/03/2023-DC (344) (link), granting a grace period for Import Licenses to qualifying Non-Regulatory Class C and D medical devices. This announcement came nearly two weeks after the October 1st deadline mentioned in G.S.R. 102 (E), which mandates Import Licenses for all Class C and D medical devices imported into India.

This grace period allows Non-Regulatory Class C and D medical devices that were registered and had pending Import License applications as of September 30, 2023, to continue their importation and marketing activities for an additional 6 months while awaiting application review. This process mirrors the one implemented for Class A and B devices last year.

Per the new Circular:

In view of the above, it has been decided that, in case, if an existing importer/manufacturer who is already importing /manufacturing any of the above said Class C or Class D Medical Devices, has submitted application to Central Licensing Authority, for grant of import/manufacturing licensce in respect of the said device(s) under the provisions of Medical Device Rules, 2017, the said application shall be deemed valid and the importer/manufacturer can continue to import /manufacture the said device(s) up to six (6) months from the date of issue of this order or till the time, the Central Licensing Authority, takes a decision on the said application, whichever is earlier.

As stated in G.S.R. 102 (E), released on February 11, 2020, all Class C and D medical devices were to be under the licensing regime beginning October 1, 2023. However, this grace period provides manufacturers with additional time to obtain their Import License(s) and ensures there is no interruption to the medical device supply in India.

For more information on registering your medical device in India, please see our dedicated page on the topic here.

Come Grow With Us

Please contact us if you’d like support from our experienced staff registering your device in India. Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Thai FDA HQ in Nonthaburi

Thai FDA QMS Updates to Affect GDP, GMP, and GCP

Last month, the Thai FDA announced new quality systems requirements that apply to the manufacture and distribution of medical devices, and for conducting clinical trials in Thailand.
Hong Kong MDD Adds China and Korea as Reference Countries- Chinese and South Korean Flags

Hong Kong MDD Adds China and Korea to List of Reference Countries

Starting January 1st, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the National Medical Products Administration (NMPA) of Mainland China and the Ministry of Food and Drug Safety (MFDS) of Korea as support of compliance of the medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS. 
Thailand FDA to Decrease Registration Application Processing Times

Thailand FDA to Decrease Registration Application Processing Times

The Thai FDA hosted a seminar for public discussion and training of the full CDST application, which was attended by Asia Actual Thailand personnel. At the event, the Thai FDA announced its intention to decrease the application pre-screening time from 30 days to 1 working day.